ILV3 Gene Detection for Candida and Aspergillus
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting fungal infections, particularly those caused by Candida and Aspergillus species, are slow and often result in unnecessary antibiotic administration due to lack of specificity and cross-reactivity with human DNA, leading to antibiotic resistance and delayed diagnosis.
Innovation Solution
The use of the ILV3 gene, which encodes dihydroxyacid dehydratase, as a novel target for molecular detection, employing specific primers and probes that do not cross-react with human DNA, allowing for rapid and specific identification of Candida and Aspergillus species using PCR and melt curve analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If molecular tests using known targets (ribosomal DNA, ILV5, or other candidate genes) are employed, then detection sensitivity may be improved, but false positive results occur due to cross-reactivity with human DNA
Solution Approach 1:
The patent extracts and isolates the ILV3 gene as a specific detection target that is unique to fungi and yeasts, separating it from human DNA sequences. By designing primers and probes that specifically bind only to the ILV3 gene, the method eliminates cross-reactivity with human genetic material while maintaining high detection sensitivity for fungal and yeast infections.
Solution Approach 2:
The patent applies local quality by designing detection reagents with sequence specificity tailored to the ILV3 gene's unique regions. The primers and probes are engineered to recognize specific local sequences within the ILV3 gene that differ from human DNA, ensuring that detection occurs only at the intended target site without off-target binding to human genomic regions.
2Reliability
If culture-based identification methods are used, then reliability of diagnosis is maintained, but detection time is excessively long (around 5 days)
Solution Approach 1:
The patent performs preliminary action by using molecular amplification methods (PCR) to rapidly detect and identify fungal and yeast DNA before clinical symptoms fully develop or before culture results are available. This allows for early diagnosis and immediate initiation of appropriate antifungal therapy, reducing the 5-day delay inherent in culture-based methods while maintaining diagnostic reliability through specific molecular targeting.
3Reliability
If broad-spectrum antibiotics are administered empirically, then coverage of potential infections is maximized, but antibiotic resistance develops due to unnecessary use
Solution Approach 1:
The patent implements feedback by providing rapid molecular diagnostic results that inform clinical decision-making. The ILV3 gene detection method delivers same-day or next-day results that feedback to clinicians, allowing them to adjust antibiotic prescribing based on actual fungal or yeast infection status. This feedback loop reduces unnecessary broad-spectrum antibiotic use by enabling targeted antifungal therapy when fungal infections are confirmed, thereby reducing the development of antibiotic resistance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, specific, and sensitive detection of fungal infections, reducing antibiotic misuse and improving diagnostic speed, thereby addressing antibiotic resistance and patient safety.
Implementation Method 1
US7291724 and US7169555 describe oligonucleotides binding to ribosomal DNA that can be used in PCR reactions
Implementation Method 2
Further amplification based methods for the detection of fungus/yeast are known
Implementation Method 3
Melt curve analysis may be employed as a method of determining which species is present in the sample
Data Source
Figure 1
Figure 2
Figure 3A
AI summary
Methods for detecting a fungal/yeast infection in a sample, comprising: performing a nucleic acid amplification reaction to amplify the ILV3 gene of fungi/yeast; and detecting the amplification product to determine whether the sample contains a fungal/yeast infection. Corresponding primers, probes and kits are also provided.